Colossal Biosciences closes funding round at ≥$20B valuation in 2026

Market overview

Given the report of ongoing talks and the company's recent revenue generation and spin-offs, it is likely Colossal will finalize a funding round at a valuation of at least $20 billion before the end of 2026.

fundraising prediction market

Implied probability (Yes)

65%

Closes

2026-12-31

More fundraising markets

• Kevin Hartz’s next fund exceeds $500M by 2027 — 65% Yes
• Inherent raises Series A of $100M+ by Feb 2027 — 55% Yes
• Malachyte to secure Series A funding by Q2 2027 — 75% Yes
• Kinship Ventures closes $75M fund by 2027 — 55% Yes
• Menlo Ventures leads Lovable round, other investors follow — 80% Yes
• Commonwealth Fusion Systems raises over $500M in 2027 — 60% Yes
• AOC's progressive PAC raises over $5 million by 2026 midterms — 75% Yes
• Linkdaze raises Series A by 2027-08-24 — 55% Yes

Browse all fundraising markets →